Skip to main content
. 2022 Sep 29;11(4):62. doi: 10.3390/antib11040062

Table 1.

IgY technologies show advantages compared to antibodies from mammals.

Area of Advantage IgY Advantage Reference
Animal care Replaces the bleeding of the animals by the collection of eggs, promoting animal welfare and reducing suffering associated with painful handling [16,17,18,19]
Biotechnology, diagnosis,
and human treatment
Low-cost production [13,14,15,16,17,18,19,20,21,22,23,24,55,56]
Antibodies against mammal conserved proteins
High-yield of production
High specificity
Can be used as polyclonal, monoclonal, Fab, or scFv
IgY Fc does not interact with Fc receptors
IgY Fc does not activate complement
Human treatment Toxic side-effects not yet reported; if used in pure form they can even be used in patients with allergy to eggs [55,56]
Passive immunization technology is applicable in newborns and adults, in immunodeficient patients and in pregnant women